LEVITRA 5 mg / 10 mg / 20 mg film-coated tablets
Animal men: 10 mg approximately 25 to 60 minutes before sexual human action. Based on efficacy and tolerability the dose may be increased to 20 mg or decreased to 5 mg. The utmost recommended dose is 20 mg once per day. Can be taken with or without food, start of action may be delayed if taken with a high fat meal. Elderly men: a first base dose of 5 mg should be used. Mild and moderate hepatic stultification, severe renal constipation: A starting dose of 5 mg should be considered. With other medicinal products: In unit with erythromycin, the dose of LEVITRA should not exceed 5 mg. Children and adolescents: not indicated.
Contraindications: Coadministration with nitrates or nitric oxide donors (such as amyl nitrite) in any form; patients who have loss of creative thinking in one eye because of NAION; men for whom sexual human activity is inadvisable (e.g. severe cardiovascular disorders); severe hepatic impairment; endstage renal disease requiring dialysis; hypotension; recent score or myocardial infarction; unstable angina; known hereditary retinal degenerative disorders; concomitant use of potent HIV protease inhibitors such as ritonavir and indinavir, concomitant use of potent CYP3A4 inhibitors (ketoconazole and itraconazole (oral form)) in men older than 75 years; sensibility to vardenafil or to any of the excipients.